Neurology and Parkinson’s disease
Clinical research is centered on advanced Parkinson’s disease, with attention to motor fluctuations and the management of ON time in people living with fluctuating symptom control.
- Motor fluctuations
- Advanced Parkinson’s disease
- ON time
The sponsor’s activity in this area reflects a focused interest in treatment approaches for movement-disorder symptoms that vary across the dosing interval.
Levodopa-based therapy
Research activity includes evaluation of levodopa treatment strategies, particularly comparison with immediate-release levodopa and associated aromatic L-amino acid decarboxylase inhibitor regimens used in Parkinson’s disease.
- Levodopa
- Immediate-release formulations
- Aromatic L-amino acid decarboxylase inhibitor
The therapeutic emphasis is on optimizing dopaminergic treatment for patients whose symptom control changes across the day.
Treatment durability and symptom control
The funded research landscape includes outcomes related to the duration of ON periods, dosing frequency, and the practical control of fluctuating motor symptoms in advanced neurodegenerative disease.
- ON periods
- Dosing frequency
- Symptom control
This area is closely tied to improving day-to-day management for patients with variable response to standard Parkinson’s therapy.
